The only FDA-approved treatment for patients with Lysosomal Acid Lipase Deficiency (LAL-D)1,2
KANUMA® (sebelipase alfa) is a hydrolytic lysosomal cholesteryl ester and triacylglycerol–specific enzyme indicated for the treatment of patients with a diagnosis of LAL-D.1
KANUMA is administered as an intravenous infusion under the supervision of a healthcare professional.1 For more information, download the full Prescribing Information and Dosing and Administration brochure below:
Getting Started on Kanuma® (sebelipase alfa)
KANUMA is approved by the U.S. Food and Drug Administration as a treatment for patients with a diagnosis of LAL-D.1
Once you have decided that KANUMA is right for your patient, here’s how OneSource™ can help you get your patients with LAL-D started on KANUMA:
Call the OneSource team at 1-888-765-4747 (Monday through Friday, 8:30 am to 8:00 pm [ET]). OneSource Customer Operations will work to facilitate order processing and delivery.
Ask your patient to sign the OneSource enrollment form to start working with a Case Manager.
Download ONESOURCE ENROLLMENT FORM
We’re Here to Help
After your patient signs up, they will be matched with a dedicated Alexion Case Manager who can help answer questions about KANUMA or
LAL-D. OneSource is staffed by Case Managers who provide one-to-one education, assistance with funding options and access to KANUMA, as well as ongoing treatment support for your patients living with LAL-D, and their caregivers.
With our experience and resources, we’re here to help your patient and their caregiver feel supported every step of the way. Here’s an overview of the services we offer.
Co Pay Program
Here are some additional services we provide to help support your patient with KANUMA
If your patient has Medicare, Medicaid, or another federal- or state-funded insurance plan, we can connect them to third-party resources that may be able to help with financial assistance.
If your patient has commercial insurance, they may be eligible for the Alexion OneSource CoPay Program, which may be able to help cover some
out-of-pocket treatment costs.
To be eligible for the CoPay Program, your patient must:
- Be signed up for patient services through OneSource
- Have commercial insurance (not part of a federal- or state-funded healthcare program)
- Be prescribed KANUMA for an FDA-approved indication
- Reside in the United States or its territories
Connect with Alexion: Medical Information